Il y a eu 50 transactions d'initiés récentes enregistrées pour Hoth Therapeutics, Inc. (HOTH), dont 41 achats et 3 ventes. Le total des achats d'initiés s'élève à $3.02M et le total des ventes d'initiés à $876K.
Les initiés notables ayant une activité récente comprennent Knie Robb, Camarra Christopher Michael, Springer Graig. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — HOTH
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2025-08-28 |
Knie Robb |
CEO and President |
Retenue Fiscale RSU |
310,744 |
$1.21 |
$376K |
547,387 |
| 2025-08-27 |
Knie Robb |
CEO and President |
Attribution de RSU |
800,000 |
- |
- |
858,131 |
| 2025-05-08 |
Camarra Christopher Michael |
Director |
Inconnu |
- |
- |
- |
- |
| 2025-01-14 |
Knie Robb |
CEO and President |
Attribution de RSU |
7,000 |
$1.55 |
$10.85K |
7,000 |
| 2025-01-14 |
Springer Graig |
Director |
Attribution de RSU |
70,000 |
$1.55 |
$108.5K |
70,000 |
| 2024-08-19 |
Knie Robb |
CEO and President |
Attribution de RSU |
325,000 |
$0.75 |
$245.31K |
325,000 |
| 2024-08-19 |
Sarnoff David |
Director |
Attribution de RSU |
25,000 |
$0.75 |
$18.87K |
25,000 |
| 2024-08-19 |
Springer Graig |
Director |
Attribution de RSU |
25,000 |
$0.75 |
$18.87K |
25,000 |
| 2024-08-19 |
Linsley Wayne |
Director |
Attribution de RSU |
25,000 |
$0.75 |
$18.87K |
25,000 |
| 2024-08-19 |
Pavell Jeff |
Director |
Attribution de RSU |
25,000 |
$0.75 |
$18.87K |
25,000 |
| 2024-08-16 |
Knie Robb |
CEO and President |
Achat Informatif |
25,000 |
$0.67 |
$16.75K |
58,131 |
| 2024-01-05 |
Knie Robb |
CEO and President |
Attribution de RSU |
225,000 |
$1.36 |
$306K |
225,000 |
| 2024-01-05 |
Sarnoff David |
Director |
Attribution de RSU |
25,000 |
$1.36 |
$34K |
25,000 |
| 2024-01-05 |
Springer Graig |
Director |
Attribution de RSU |
25,000 |
$1.36 |
$34K |
25,000 |
| 2024-01-05 |
Linsley Wayne |
Director |
Attribution de RSU |
25,000 |
$1.36 |
$34K |
25,000 |
| 2024-01-05 |
Pavell Jeff |
Director |
Attribution de RSU |
25,000 |
$1.36 |
$34K |
25,000 |
| 2023-07-17 |
Knie Robb |
CEO and President |
Attribution de RSU |
40,000 |
$2.59 |
$103.6K |
40,000 |
| 2023-07-17 |
Sarnoff David |
Director |
Attribution de RSU |
7,500 |
$2.59 |
$19.43K |
7,500 |
| 2023-07-17 |
Springer Graig |
Director |
Attribution de RSU |
7,500 |
$2.59 |
$19.43K |
7,500 |
| 2023-07-17 |
Linsley Wayne |
Director |
Attribution de RSU |
7,500 |
$2.59 |
$19.43K |
7,500 |
| 2023-07-17 |
Pavell Jeff |
Director |
Attribution de RSU |
7,500 |
$2.59 |
$19.43K |
7,500 |
| 2022-12-13 |
Pavell Jeff |
Director |
Attribution de RSU |
5,075 |
- |
- |
5,075 |
| 2022-12-07 |
Pavell Jeff |
Director |
Inconnu |
- |
- |
- |
- |
| 2022-09-19 |
Knie Robb |
CEO and President |
Achat Informatif |
10,000 |
$0.39 |
$3.9K |
828,259 |
| 2022-09-16 |
Knie Robb |
CEO and President |
Achat Informatif |
10,000 |
$0.40 |
$4K |
818,259 |
| 2022-03-16 |
Knie Robb |
CEO and President |
Attribution de RSU |
500,000 |
$0.59 |
$295.5K |
500,000 |
| 2022-03-16 |
Sarnoff David |
Director |
Attribution de RSU |
40,000 |
- |
- |
40,000 |
| 2022-03-16 |
Springer Graig |
Director |
Attribution de RSU |
250,000 |
- |
- |
250,000 |
| 2022-03-16 |
Linsley Wayne |
Director |
Attribution de RSU |
40,000 |
- |
- |
40,000 |
| 2022-03-16 |
Johns Stefanie |
Chief Scientific Officer |
Attribution de RSU |
250,000 |
$0.59 |
$147.75K |
250,000 |
| 2021-01-29 |
Mats Vadim |
Director |
Attribution de RSU |
33,000 |
$2.11 |
$69.63K |
33,000 |
| 2021-01-29 |
Knie Robb |
CEO and President |
Attribution de RSU |
225,000 |
$2.11 |
$474.75K |
225,000 |
| 2021-01-29 |
Sarnoff David |
Director |
Attribution de RSU |
33,000 |
$2.11 |
$69.63K |
33,000 |
| 2021-01-29 |
Springer Graig |
Director |
Attribution de RSU |
33,000 |
$2.11 |
$69.63K |
33,000 |
| 2021-01-29 |
Linsley Wayne |
Director |
Attribution de RSU |
33,000 |
$2.11 |
$69.63K |
33,000 |
| 2021-01-29 |
Johns Stefanie |
Chief Scientific Officer |
Attribution de RSU |
125,000 |
$2.11 |
$263.75K |
125,000 |
| 2020-12-31 |
Knie Robb |
CEO and President |
Inconnu |
- |
- |
- |
- |
| 2020-12-31 |
Aikido Pharma Inc. |
10 Percent Owner |
Inconnu |
- |
- |
- |
- |
| 2020-09-08 |
Johns Stefanie |
Officer |
Inconnu |
- |
- |
- |
- |
| 2020-07-21 |
Rice Kenneth L Jr |
Director |
Attribution de RSU |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-07-21 |
Mats Vadim |
Director |
Attribution de RSU |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-07-21 |
Knie Robb |
CEO and President |
Attribution de RSU |
80,000 |
$3.05 |
$244K |
80,000 |
| 2020-07-21 |
Sarnoff David |
Director |
Attribution de RSU |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-07-21 |
Springer Graig |
Director |
Attribution de RSU |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-07-21 |
Linsley Wayne |
Director |
Attribution de RSU |
15,000 |
$3.05 |
$45.75K |
15,000 |
| 2020-05-26 |
Hayes Anthony |
Officer |
Vente Informative |
- |
- |
- |
- |
| 2020-05-26 |
Hayes Anthony |
10 Percent Owner |
Vente Informative |
400,000 |
$1.25 |
$500K |
1,130,674 |
| 2020-04-15 |
Springer Graig |
Director |
Attribution de RSU |
3,333 |
- |
- |
3,333 |
| 2020-04-15 |
Linsley Wayne |
Director |
Inconnu |
- |
- |
- |
- |
| 2020-04-15 |
Linsley Wayne |
Director |
Attribution de RSU |
3,333 |
- |
- |
3,333 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi